The Effect Of Fesoterodine On Pharmacokinetics And Pharmacodynamics Of Warfarin In Healthy Subjects
Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
This is an open-label, randomized, two-way crossover study to evaluate the steady-state
effect of fesoterodine (8 mg QD) on the pharmacodynamics and pharmacokinetics of a single
supratherapeutic dose of warfarin (25 mg) in healthy subjects.